Update on aspirin in the treatment and prevention of cardiovascular disease

American Heart Journal

Volumn 137, Issue 4 II, 1999, Pages

  Hennekens, C H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; BETA CAROTENE; DIPYRIDAMOLE; STREPTOKINASE; SULFINPYRAZONE; THROMBOXANE B2;

ACUTE HEART INFARCTION; ANTICOAGULATION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DISEASE ASSOCIATION; HEART DEATH; HEART REINFARCTION; HIGH RISK POPULATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; STROKE; TRANSIENT ISCHEMIC ATTACK; TREATMENT PLANNING; UNSTABLE ANGINA PECTORIS;

EID: 0032937802     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-8703(99)70391-1     Document Type: Review

References (23)

1. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971;231:232-5.
2. Hennekens CH, Buring JE, Sandercock P, et al. Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease. Circulation 1989;80:749-56.
3. Fuster V, Dyken ML, Vokonas PS, et al. Aspirin as a therapeutic agent in cardiovascular disease. Circulation 1993;87:659-75.
4. Hennekens CH, Dyken ML, Foster V. Aspirin as a therapeutic agent in cardiovascular disease. Circulation 1997;96:2751-3.
5. Antiplatelet Trialists' Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet therapy. BMJ 1988;296:320-32.
6. Antiplatelet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy, I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81-106.
7. Aspirin for heart patients. FDA Drug Bull 1985;15:34-6.
8. Aspirin for TIAs. FDA Drug Bull 1980;10:2.
9. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;2:349-60.
10. Reilly IAG, FitzGerald GA. Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy and platelet inhibitory drugs. Blood 1987;69:180-6.
11. US Food and Drug Administration. Internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use: proposed amendment to the tentative Final Monograph. Federal Register. June 13, 1996;61:30002.
12. UK-TIA Study Group. United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results. Br Med J 1988;296:316-20.
13. Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med 1989;321:129-35.
14. Peto R, Gray R, Collins R, et al. Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J 1988;296:313-6.
15. Manson JE, Stampfer MJ, Colditz GA, et al. A prospective study of aspirin use and primary prevention of cardiovascular disease in women. JAMA 1991;266:521-7.
16. Boston Collaborative Drug Surveillance Group. Regular aspirin intake and acute myocardial infarction. Br Med J 1974;1:440-3.
17. Hammond EC, Garfinkel L. Aspirin and coronary heart disease: findings of a prospective study. Br Med J 1975;2:269-71.
18. Paganini-Hill A, Chao A, Ross RK, et al. Aspirin use and chronic diseases: a cohort study of the elderly. Br Med J 1989;299:1247-50.
19. Centers for Disease Control. Coronary heart disease incidence, by sex: United States, 1971-1987. MMWR 1992;41:526-9.
20. Robins M, Baum HM. The National Survey of Stroke Incidence. Stroke 1981;12(suppl I):I-45-I-57.
21. Buring JE, Hennekens CH, for the Women's Health Study Research Group: The Women's Health Study: rationale and background. J Myocard Isch 1992;4:30-40.
22. Buring JE, Hennekens CH, for the Women's Health Study Research Group: The Women's Health Study: summary of the study design. J Myocard Isch 1992;4:27-9.
23. US Preventive Services Task Force. Aspirin prophylaxis for the primary prevention of myocardial infarction: guide to clinical preventive services. 2nd edition. Baltimore: Williams & Williams; 1996. p 845-51.